インフルエンザ誘発の病原性およびピランポリマー結合SODによる治療における酸素ラジカル
1Department of Microbiology, Kumamoto University Medical School, Japan.
Science (New York, N.Y.)
|May 26, 1989
まとめ
ネズミのインフルエンザウイルス感染の重症度は,単にウイルス増殖ではなく,免疫過剰反応によるものです. スーパーオキシドディスミュータゼ (SOD) 治療は,感染中に有害な酸素ラジカルを中和することによって潜在的な効果を示しています.
科学分野:
- 免疫学 免疫学とは
- ウイルス学 ウイルス学 ウイルス学
- バイオケミストリー バイオケミストリー
背景:
- インフルエンザウイルスの病原性は,宿主の免疫過剰反応と関連しています.
- 増加したキサンチン酸化酵素と酸素のフリーラジカル生成は,インフルエンザ感染中に発生します.
研究 の 目的:
- インフルエンザの病原性における酸素フリーラジカルの役割を調査する.
- インフルエンザの治療におけるスーパーオキシドディスミュータゼ (SOD) の治療の可能性を評価する.
主な方法:
- インフルエンザウイルスに感染したマウス.
- ポリマー結合型スーパーオキシドディスミュータゼ (SOD) を自由基除去剤として投与する.
- 致命的なインフルエンザ感染に対する評価された保護.
主要な成果:
- ポリマー結合SOD投与は,致命的なインフルエンザからマウスを保護しました.
- 感染後5~8日後にSODを投与したときに観察された治療効果.
- 酸素ラジカルは,インフルエンザの病原性において重要な役割を果たします.
結論:
- 酸素のフリーラジカルは,インフルエンザウイルス感染症の病理学に重要な貢献者です.
- ポリマー結合SODは,インフルエンザやその他のフリーラジカルに関連した疾患に対する治療の有望性を示しています.
関連する概念動画
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...